Nature, Published online: 01 October 2025; doi:10.1038/s41586-025-09580-0

A combined sequencing technique assesses 18 patients with high-grade serous ovarian cancer over a multi-year period from diagnosis to recurrence and shows drug resistance typically arises from selective expansion of one or a few clones present at diagnosis.

From Nature via this RSS feed